Citadel Advisors’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.38K | Sell |
|
|||||
|
2024
Q4 | $61.9K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $413K | Sell |
|
|||||
|
2024
Q1 | $13.8M | Buy |
|
|||||
|
2023
Q4 | $18.4M | Buy |
|
|||||
|
2023
Q3 | $2.04M | Buy |
|
|||||
|
2023
Q2 | $1.52M | Sell |
|
|||||
|
2023
Q1 | $1.1M | Buy |
|
|||||
|
2022
Q4 | $1.59M | Sell |
|
|||||
|
2022
Q3 | $2.28M | Buy |
|
|||||
|
2022
Q2 | $633K | Sell |
|
|||||
|
2022
Q1 | $2.27M | Buy |
|
|||||
|
2021
Q4 | $1.9M | Sell |
|
|||||
|
2021
Q3 | $6.92M | Buy |
|
|||||
|
2021
Q2 | $1.23M | Sell |
|
|||||
|
2021
Q1 | $4.37M | Sell |
|
|||||
|
2020
Q4 | $24.4M | Buy |
|